Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/96BBAA0C83A779BC77DBB1546DE3531EE6C668980453F64F0D246B1A9BFBD53EAB679AE9C94117E83AE548273C65814Ehttp://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/96BBAA0C83A779BC77DBB1546DE3531EE6C668980453F64F0D246B1A9BFBD53EAB679AE9C94117E83AE548273C65814Ehttp://www.w3.org/2000/01/rdf-schema#comment"p-SMAD2/3 proteins were remarkably increased in bladder carcinoma. High p-SMAD2/3 was not statistically associated with clinicopathological characteristics of the patients. Overexpression of hepaCAM prevented the p-SMAD2/3 translocation from the cytoplasm to the nucleus in bladder cancer cells. The p-SMAD2/3 pathway is critical for hepaCAM-induced cancer cell apoptosis."xsd:string
http://purl.uniprot.org/uniprot/#_7635AD3D60124A1C3C9E4B7B6304EB3E55C3736E44A12A2BCA43E0A33881F663B680ECDDF622F8E38A7D7D317A2A375Chttp://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/96BBAA0C83A779BC77DBB1546DE3531EE6C668980453F64F0D246B1A9BFBD53EAB679AE9C94117E83AE548273C65814E
http://purl.uniprot.org/uniprot/P84022http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/96BBAA0C83A779BC77DBB1546DE3531EE6C668980453F64F0D246B1A9BFBD53EAB679AE9C94117E83AE548273C65814E
http://purl.uniprot.org/uniprot/#_P84022-mappedCitation-26873485http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/96BBAA0C83A779BC77DBB1546DE3531EE6C668980453F64F0D246B1A9BFBD53EAB679AE9C94117E83AE548273C65814E